{"success":true,"data":{"pressRelease":{"id":"9703","rtpr_id":"nBw3yllTla","ticker":"TVTX","exchange":"NASDAQ","all_tickers":["TVTX"],"title":"Travere Therapeutics to Report First Quarter 2026 Financial Results","author":"Business Wire","published_at":"2026-04-27T20:30:00.216Z","article_body":"Travere Therapeutics to Report First Quarter 2026 Financial Results\n\nTravere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report first\nquarter 2026 financial results on Monday, May 4, 2026, after the close of the\nU.S. financial markets. The Company will host a conference call and webcast to\ndiscuss the financial results and provide a general business update at 4:30\np.m. ET.\n\nThe webcast and dial-in information can be accessed on the Investor page of\nTravere’s website at https://ir.travere.com/events-and-presentations\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fir.travere.com%2Fevents-and-presentations&esheet=54523668&newsitemid=20260427119922&lan=en-US&anchor=https%3A%2F%2Fir.travere.com%2Fevents-and-presentations&index=1&md5=9b0f848ddf7c2cd330f90174f198fe77)\n. Following the live webcast, an archived version of the call will be\navailable for 30 days on the Company’s website.\n\nAbout Travere Therapeutics\n\nAt Travere Therapeutics, we are in rare for life. We are a biopharmaceutical\ncompany that comes together every day to help patients, families, and\ncaregivers of all backgrounds as they navigate life with a rare disease. On\nthis path, we know the need for treatment options is urgent – that is why\nour global team works with the rare disease community to identify, develop,\nand deliver life-changing therapies. In pursuit of this mission, we\ncontinuously seek to understand the diverse perspectives of rare patients and\nto courageously forge new paths to make a difference in their lives and\nprovide hope – today and tomorrow. For more information, visit travere.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftravere.com%2F&esheet=54523668&newsitemid=20260427119922&lan=en-US&anchor=travere.com&index=2&md5=a0a1279cb31b05ea25d22a9d4dcdeb6c)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260427119922/en/\n(https://www.businesswire.com/news/home/20260427119922/en/)\n\nMedia:\n\n888-969-7879\n\nmediarelations@travere.com \n(mailto:mediarelations@travere.com) \n\n\nInvestors:\n\n888-969-7879\n\nIR@travere.com (mailto:IR@travere.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw3yllTla","title":"Travere Therapeutics to Report First Quarter 2026 Financial Results","author":"Business Wire","ticker":"TVTX","created":"2026-04-27T20:30:00.216Z","tickers":["TVTX"],"exchange":"NASDAQ","article_body":"Travere Therapeutics to Report First Quarter 2026 Financial Results\n\nTravere Therapeutics, Inc. (Nasdaq: TVTX) today announced it will report first\nquarter 2026 financial results on Monday, May 4, 2026, after the close of the\nU.S. financial markets. The Company will host a conference call and webcast to\ndiscuss the financial results and provide a general business update at 4:30\np.m. ET.\n\nThe webcast and dial-in information can be accessed on the Investor page of\nTravere’s website at https://ir.travere.com/events-and-presentations\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fir.travere.com%2Fevents-and-presentations&esheet=54523668&newsitemid=20260427119922&lan=en-US&anchor=https%3A%2F%2Fir.travere.com%2Fevents-and-presentations&index=1&md5=9b0f848ddf7c2cd330f90174f198fe77)\n. Following the live webcast, an archived version of the call will be\navailable for 30 days on the Company’s website.\n\nAbout Travere Therapeutics\n\nAt Travere Therapeutics, we are in rare for life. We are a biopharmaceutical\ncompany that comes together every day to help patients, families, and\ncaregivers of all backgrounds as they navigate life with a rare disease. On\nthis path, we know the need for treatment options is urgent – that is why\nour global team works with the rare disease community to identify, develop,\nand deliver life-changing therapies. In pursuit of this mission, we\ncontinuously seek to understand the diverse perspectives of rare patients and\nto courageously forge new paths to make a difference in their lives and\nprovide hope – today and tomorrow. For more information, visit travere.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Ftravere.com%2F&esheet=54523668&newsitemid=20260427119922&lan=en-US&anchor=travere.com&index=2&md5=a0a1279cb31b05ea25d22a9d4dcdeb6c)\n.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260427119922/en/\n(https://www.businesswire.com/news/home/20260427119922/en/)\n\nMedia:\n\n888-969-7879\n\nmediarelations@travere.com \n(mailto:mediarelations@travere.com) \n\n\nInvestors:\n\n888-969-7879\n\nIR@travere.com (mailto:IR@travere.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-04-27T20:30:00.257113088Z","server_sent_at_ms":1777321800257},"received_at":"2026-04-27T20:30:00.321Z","source_url":"https://www.businesswire.com/news/home/20260427119922/en/"},"analysis":{"id":"7369","press_release_id":"9703","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Travere Therapeutics announced it will report its first quarter 2026 financial results on Monday, May 4, 2026, following the close of the U.S. financial markets.\n\nA conference call and webcast are scheduled for 4:30 p.m. ET on the same day to discuss the results and provide a general business update.\n\nAccess details for the live event and the subsequent 30-day archive will be available on the Investor Relations section of the company's website.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine earnings scheduling update."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[],"products":[],"companies":[{"name":"Travere Therapeutics, Inc.","ticker":"TVTX"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"This is a routine administrative announcement regarding the timing of an upcoming earnings release and conference call. No financial data, guidance, or material business events were disclosed."},"tickerRelevance":{"others":[],"primary":"TVTX"},"globalImportance":5,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small/mid-cap biotech","eventGravity":"administrative scheduling","sectorWeight":"niche healthcare"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Travere Therapeutics announced it will report its first quarter 2026 financial results on Monday, May 4, 2026, following the close of the U.S. financial markets.\n\nA conference call and webcast are scheduled for 4:30 p.m. ET on the same day to discuss the results and provide a general business update.\n\nAccess details for the live event and the subsequent 30-day archive will be available on the Investor Relations section of the company's website.","key_figures":{},"named_entities":{"people":[],"products":[],"companies":[{"name":"Travere Therapeutics, Inc.","ticker":"TVTX"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:1fc968c3ac7f7ebb","schema_hash":"sha256:1f8af1196c7db48c","created_at":"2026-04-27T20:53:45.527Z","global_importance":5,"audience_relevance":10,"importance_components":{"tickerTier":"small/mid-cap biotech","eventGravity":"administrative scheduling","sectorWeight":"niche healthcare"}},"durationMs":40162,"modelName":"glm-4.7"}}